Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin

被引:42
作者
Fiorucci, S
Distrutti, E
Mencarelli, A
Morelli, A
Laufer, SA
Cirino, G
Wallace, JL
机构
[1] Univ Perugia, Clin Gastroenterol & Epatol, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy
[2] Univ Tubingen, Dept Pharmaceut & Med Chem, Inst Pharm, Tubingen, Germany
[3] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy
[4] Univ Calgary, Dept Pharmacol, Calgary, AB T2N 1N4, Canada
关键词
leukotriene B4; lipoxin; aspirin-triggered lipoxin; neutrophils/endothelium adherence; aspirin; 5-lipoxigenase; cyclooxygenase; celcoxib; rofecoxib;
D O I
10.1038/sj.bjp.0705356
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Unlike other nonsteroidal anti-inflammatory drugs that inhibit formation of cyclooxygenase (COX)-dependent eicosanoids, acetylation of COX-2 by aspirin switches eicosanoid biosynthesis from prostaglandin E-2 (PGE(2)) to 15-epi-lipoxin A(4) (15-epi-LXA(4) or aspirin-triggered lipoxin, ATL). ATL formation by activated leukocytes (PMN) requires the intervention of 5-lipoxygenase (5-LOX), an enzyme that is involved in leukotriene B-4 (LTB4) formation. 2 In the present study, we have examined the role of acetylated COX-2 and 5-LOX in modulating antiadhesive effects of aspirin on adhesion of PMN to endotoxin (LPS)-primed human umbilical endothelial cells ( HUVEC). 3 Treating PMN/HUVEC cocultures with aspirin resulted in a concentration-dependent inhibition of cell-to-cell adhesion induced by LPS. Treating HUVEC with selective COX-2 inhibitors, celecoxib and rofecoxib, caused an approximate to70% reversion of antiadhesive effect of aspirin. In contrast, inhibition of neutrophil's 5-LOX pathway with 1 muM ZD2138, a selective 5-LOX inhibitor, 1 muM BAY-X-1005, a FLAP inhibitor, or 100 muM licofelone, a dual COX/5-LOX inhibitor, did not affect antiadhesive properties of aspirin. 4 Exposure to celecoxib (100 muM) or rofecoxib (10 muM) completely suppressed ATL formation caused by aspirin without affecting LTB4 levels. ZD2138, licofelone and BAY-X-1005 inhibited ATL formation as well as LTB4 generation. 5 Treatment with LXA(4) reduced PMN adhesion to HUVEC and counteracted the proadhesive effect of celecoxib. In contrast, exposure to Boc-1, an LXA(4) antagonist, counteracts the antiadhesive activities of aspirin. Exposure to U75302, an LTB4 receptor antagonist, enhances the antiadesive effect of aspirin. 6 Reversal of antiadhesive activities of aspirin by celecoxib was associated with increased expression of LFA-1 on PMN and E-selectin on HUVEC. Addition of LXA(4), ZD2138 and U75302 inhibited these changes. 7 The present results support the notion that inhibition of ATL formation is mechanistically linked to the reversal of the antiadhesive activity of aspirin caused by selective COX-1 inhibitors and suggests that the LTB4/ATL balance modulates pro- and antiadhesive activity of nonsteroidal antiinflammatory drugs at the leukocyte-endothelial cell interface.
引用
收藏
页码:1351 / 1359
页数:9
相关论文
共 34 条
[1]  
ALPIN AE, 1998, PHARMACOL REV, V50, P197
[2]   Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases [J].
Boutaud, O ;
Aronoff, DM ;
Richardson, JH ;
Marnett, LJ ;
Oates, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :7130-7135
[3]  
CARLOS TM, 1994, BLOOD, V84, P2068
[4]   COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression [J].
Chandrasekharan, NV ;
Dai, H ;
Roos, KLT ;
Evanson, NK ;
Tomsik, J ;
Elton, TS ;
Simmons, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13926-13931
[5]  
Chiang N, 1998, J PHARMACOL EXP THER, V287, P779
[6]   ASPIRIN TRIGGERS PREVIOUSLY UNDESCRIBED BIOACTIVE EICOSANOIDS BY HUMAN ENDOTHELIAL CELL-LEUKOCYTE INTERACTIONS [J].
CLARIA, J ;
SERHAN, CN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9475-9479
[7]   Anti-inflammatory actions of lipoxin A4 stable analogs are demonstrable in human whole blood:: Modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions [J].
Filep, JG ;
Zouki, C ;
Petasis, NA ;
Hachicha, M ;
Serhan, CN .
BLOOD, 1999, 94 (12) :4132-4142
[8]   Lipoxin A(4) receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: Inhibition of CD11/18 expression by lipoxin A(4)-lipoxin A(4) receptor interaction [J].
Fiore, S ;
Serhan, CN .
BIOCHEMISTRY, 1995, 34 (51) :16678-16686
[9]   Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage [J].
Fiorucci, S ;
de Lima, OM ;
Mencarelli, A ;
Palazetti, B ;
Distrutti, E ;
McKnight, W ;
Dicay, M ;
Ma, L ;
Romano, M ;
Morelli, A ;
Wallace, JL .
GASTROENTEROLOGY, 2002, 123 (05) :1598-1606
[10]   Drug therapy: The coxibs, selective inhibitors of cyclooxygenase-2. [J].
FitzGerald, GA ;
Patrono, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06) :433-442